Summary
- The court is set to deliver a ruling on the regulation of "零売薬局" (retail pharmacies) allowing the sale of pharmaceuticals without prescriptions on the 18th.
- This case raises critical questions about the balance between public health and access to medications.
- Stakeholders are closely watching how this decision may impact pharmacy practices and patient care in Japan.
- The implications of the ruling could reshape pharmaceutical regulations and accessibility for consumers nationwide.
Join the discussion — sign up to comment, upvote, and save articles.